Transcriptomic signatures in sepsis and a differential response to steroids: from the VANISH randomized trial
<strong>Rationale:</strong> There remains uncertainty about the role of corticosteroids in sepsis with clear beneficial effects on shock duration but conflicting survival effects. Two transcriptomic sepsis response signatures (SRS) have been identified. SRS1 is relatively immunosuppresse...
Main Authors: | Antcliffe, D, Burnham, K, Al-Beidh, F, Santhakumaran, S, Brett, S, Hinds, C, Ashby, D, Knight, J, Gordon, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Thoracic Society
2018
|
Similar Items
-
Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia
by: Burnham, K, et al.
Published: (2016) -
Genes and sepsis: how tight is the fit?
by: Gordon, A, et al.
Published: (2008) -
Epstein-Barr virus reactivation in sepsis due to community-acquired pneumonia is associated with increased morbidity and an immunosuppressed host transcriptomic endotype
by: Goh, C, et al.
Published: (2020) -
An immune-cell signature of bacterial sepsis
by: Reyes, Miguel, et al.
Published: (2020) -
Functional genomics of the sepsis response
by: Burnham, K
Published: (2017)